Suchergebnisse - "Guo, Huimin"

PubPharm (379)

1

Discovery of Highly Potent Solute Carrier 13 Member 5 (SLC13A5) Inhibitors for the Treatment of Hyperlipidemia

enthalten in: Journal of medicinal chemistry | 2024

von Zhang, L. | Hu, W. | Guo, H. | +5

2

Corrigendum to "construction of bionanoparticles based on Angelica polysaccharides for the treatment of stroke" [nanomedicine : Nanotechnology, biology and medicine 44 (2022) 102570

enthalten in: Nanomedicine : nanotechnology, biology, and medicine | 2024

von Su, Y. | Guo, C. | Chen, Q. | +4

ErratumFor: Nanomedicine. 2022 Aug;44:102570. - PMID 35623564

3

Key phytochemicals contributing to the bitterness of quinoa

enthalten in: Food chemistry | 2024

von Guo, H. | Wang, S. | Liu, C. | +4

4

Nanopore-based metagenomics analysis reveals microbial presence in amniotic fluid : A prospective study

enthalten in: Heliyon | 2024

von Zhong, L. | Yan, Y. | Chen, L. | +10

5

Drosophila eIF3f1 mediates host immune defense by targeting dTak1

enthalten in: EMBO reports | 2024

von Hu, Y. | Kong, F. | Guo, H. | +7

6

Microbial-Transferred Metabolites and Improvement of Biological Activities of Green Tea Catechins by Human Gut Microbiota

enthalten in: Foods (Basel, Switzerland) | 2024

von Su, Y. | Hu, K. | Li, D. | +3

7

The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8

enthalten in: mBio | 2024

von Fan, L. | Zhou, Y. | Wei, X. | +11

8

Drosophila eIF3f1 mediates host immune defense by targeting dTak1

enthalten in: EMBO Reports | 2024

von Hu, Y. | Kong, F. | Guo, H. | +7

9

Stratified Prognostic Comparison Between Stage IIB-IVA Cervical Adenocarcinoma and Squamous Cell Carcinoma : A SEER Database-Based Study

enthalten in: International journal of women's health | 2024

von Guo, H. | Gao, S. | Kong, W.

10

The application of nanopore targeted sequencing for pathogen diagnosis in bronchoalveolar lavage fluid of patients with pneumonia : a prospective multicenter study

enthalten in: Infectious diseases (London, England) | 2024

von Lin, Q. | Yao, Y. | Li, X. | +19

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[38]